Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the most frequent primary liver tumor. As a result of advanced disease being often present at diagnosis, only a small percentage of patients are amenable to curative-intent treatment options such as surgical resection and liver transplantation. Systemic therapy cons...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2022-04, Vol.14 (8), p.2018
Hauptverfasser:	Machairas, Nikolaos, Tsilimigras, Diamantis I, Pawlik, Timothy M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Antigens Cancer therapies Clinical trials Cytotoxicity Hepatitis B Hepatitis C Hepatocellular carcinoma Immune checkpoint inhibitors Immunotherapy Infections Liver cancer Liver cirrhosis Liver diseases Liver transplantation Lymphocytes Malignancy Medical research Patients Protein-tyrosine kinase Review Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!